Get started
HCA Healthcare IncHCA Healthcare IncHCA Healthcare Inc

HCA Healthcare Inc

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Trade ideas

HCA Healthcare I observe a clear rotation of capital into the healthcare sector, with strong inflows toward medical companies reporting solid earnings and outlooks. Within this rotation, HCA Healthcare appears to be the most attractively valued company, supported by consistent profitability, a strong balance sheet, and long-term growth prospects. I consider HCA a high-quality name positioned to benefit from the current shift in market focus toward fundamental strength and stability. I'll play this with a call spread to collect some premium due to the bid prices on these calls...
NYSE:HCALong
by OssianH
HCA - Precision Swing Long (Consistent Technical Alignment)🎯 Ticker: HCA (NYSE) 📈 Type: Swing Long ⏰ Timeframe: Daily (D1) & 4H 📊 Multi-Timeframe Technical Analysis: Daily Trend: BULLISH ✅ Technical Alignment: BUY Signals Across All Timeframes (Daily, 4H, 1H) Key Support: $450-455 zone (Confluence of SMA 20 & previous resistance) Momentum: RSI (57.6) shows healthy momentum with room to run 💡 Trading Thesis: HCA presents a high-quality technical setup supported by strong fundamentals: PERFECT TECHNICAL ALIGNMENT: Rare "Triple Buy" signal across daily, 4H, and 1H timeframes Trading above all key moving averages in clear uptrend Recent breakout above $455 resistance now acting as support SOLID FUNDAMENTAL BACKDROP: Moderate Growth Profile: Steady revenue and earnings growth Attractive Valuation: Fair P/E (17.7) and P/S (1.4) ratios Sector Strength: Healthcare services showing resilience INSTITUTIONAL SUPPORT: Strong volume on up days confirms institutional accumulation Healthcare sector benefiting from demographic tailwinds ⚡ Precision Trading Plan: 🎯 Entry: $462.87 (Optimal risk-reward entry zone) 🛑 Stop Loss: $440.64 (Below key support cluster and SMA 50) 💰 Profit Target: $508.97 (Previous highs + measured move extension) 📊 Risk/Reward Ratio: 1:2.8 (Exceptional for swing trade) 📉 Risk Management Notes: Stop loss strategically placed below critical $450-455 support zone Consider partial profit taking at $495-500 area Monitor healthcare sector sentiment for broader market moves Only 2% maximum portfolio risk per position recommended Conclusion: HCA offers a clean technical setup with perfect alignment across timeframes and strong fundamental support. The exceptional risk-reward ratio makes this a high-probability swing trade opportunity. Trade with discipline and proper position sizing! Disclaimer: This is not investment advice. Conduct your own research and manage risk according to your personal tolerance and strategy. #HCA #SwingTrading #Long #Healthcare #TechnicalAnalysis #Breakout #HCAHealthcare
NYSE:HCALong
by shortermtrader
HCA - High-Probability Swing Trade with Connors ConfirmationHCA - HCA Healthcare, Inc. 🏥 Strong Buy Signal | Confirmed by Fundamentals, Technicals & Connors RSI2 🎯 Trade Idea Overview Direction: LONG Entry Zone: $429 - $433 Stop Loss: $406.70 Take Profit: $484.96 Strategy: Swing to Position Trade (2–6 weeks) Confidence Level: High (85%) 📊 Why HCA? ✅ Fundamental Strength (Score: 5/9) Revenue Growth: Moderate 📈 Net Income Growth: Moderate 💹 Valuation: Fairly Valued (P/E 17.6) Debt Health: Acceptable (Score: 7/10) Sector Stability: Healthcare – Defensive Sector 🛡️ ✅ Technical Alignment Daily Trend: ✅ Bullish 4H Trend: ✅ Bullish 1H Trend: 🔁 Bearish (Short-term Pullback) → Ideal Entry Opportunity Price Action: Trading near key support, poised for continuation Momentum: Bullish structure intact across higher timeframes ✅ Connors RSI2 Confirmation Buy Signal: Active on Oct 10 & 13 (Double Confirmation) Strategy: RSI2 momentum shift + trend alignment Timing: Signal remains valid within optimal 5-10 day window 📍 Entry & Risk Management Recommended Entry: $431 (market or limit) Stop Loss: $406.70 (5.6% risk) Take Profit: $484.96 (12.5% reward) R/R Ratio: 1:2.23 ✅ 🧠 Trade Rationale HCA presents a strong technical setup aligned with defensive sector strength. Double Connors RSI2 buy signal (Oct 10 & 13) confirms short-term momentum shift. Current pullback to $430 zone offers optimal risk/reward entry. Healthcare sector provides stability during market uncertainty. 📆 Watch List Monitor for bullish confirmation above $435. Watch healthcare sector news and overall market sentiment. Key earnings date: November (Q3 2025) ✅ Summary Asset: HCA Action: BUY Entry: $431 SL: $406.70 TP: $484.96 Signal Type: Multi-timeframe + Double Connors RSI2 Confirmed ‼️ Disclaimer This analysis is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Trading involves substantial risk and is not suitable for every investor. You should carefully consider your investment objectives, experience level, and risk tolerance before acting on any information provided. The author is not a registered financial advisor and assumes no liability for any trading losses or damages resulting from this information. Past performance is not indicative of future results. Always conduct your own due diligence and consult with a qualified financial professional before making any investment decisions.
NYSE:HCALong
by shortermtrader
HCA Healthcare | HCA | Long at $299.00NYSE:HCA Healthcare: P/E of 13x, earnings are forecast to grow 6.01% per year; earnings have grown 10.6% per year over the past 5 years, and trading at good value compared to peers and industry. From a technical analysis perspective, it dipped to my selected historical simple moving average area and may represent a buying opportunity to fill the daily price gap up to $394.00. Thus, NYSE:HCA is in a personal buy zone at $299.00. Target #1 = $324.00 Target #2 = $362.00 Target #3 = $394.00
NYSE:HCALong
by WorthlessViews
HCA EARNINGS TRADE (07/24) 🚨 HCA EARNINGS TRADE (07/24) 🚨 🏥 Healthcare with earnings tonight after close — high-upside setup brewing. 🧠 Quick Breakdown: • 📊 Revenue Growth: +5.7% (stable, defensive sector) • 💸 Margins: Operating 15.6%, EBITDA 19.9% = efficient and strong • 🧠 Beat Rate: 75% with 6.7% avg surprise → credible upside • 📉 RSI: 22.5 → OVERSOLD and primed for bounce • 💬 Whisper sentiment strong from sector peers (e.g., Tenet) • 🔥 Analysts target: $391.54 → 13.8% upside 💥 TRADE SETUP 🟢 Buy HCA $375 Call exp 8/15 💰 Entry: $3.90 🎯 Target: $11.70 (200–300%) 🛑 Stop: $1.95 📈 Confidence: 73% ⏰ Entry: Before Close Today (Pre-Earnings) 📆 Earnings: Today After Market (AMC) 📊 IV Rank: 0.60 → fair pricing 📉 Expected Move: ~5% ⚠️ RSI this low + sector strength = earnings bounce candidate. Watch the $375 breakout zone. 🎯 #HCA #EarningsPlay #OptionsTrading #HealthcareStocks #UnusualOptionsActivity #CallOptions #TradingView #DayTrading #OversoldBounce #EarningsSeason
NYSE:HCALong
by quantsignals
HCA exhibits strong financial health!Technical Analysis HCA's stock has demonstrated resilience, with a 52-week range between $276.50 and $417.14. The Relative Strength Index (RSI) stands at 58.01, suggesting the stock is neither overbought nor oversold. The Moving Average Convergence Divergence (MACD) is 0.11, indicating a potential upward momentum. However, some technical indicators present a neutral to bearish outlook in the short to mid-term. For instance, the stock's short-term trend appears neutral, while mid-term indicators lean bearish. Fundamental Analysis From a fundamental perspective, HCA exhibits strong financial health. The company maintains a Price-to-Earnings (P/E) ratio of 13.92, which is competitive within the Healthcare Facilities industry. Its Price-to-Sales (P/S) ratio is 1.16, closely aligning with the industry average of 1.11. The Price-to-Cash Flow multiple stands at 40.51, and the Price/Earnings to Growth (PEG) ratio is 1.51, indicating balanced growth relative to earnings. CSIMARKET.COM Recent earnings reports highlight HCA's robust performance. In the fourth quarter ending December 31, 2024, the company reported revenues of $18.285 billion, up from $17.303 billion in the same period the previous year. Same-facility admissions increased by 3.0%, reflecting strong demand for medical services. Despite challenges from Hurricanes Helene and Milton, which led to a 60-cent charge per share, adjusted earnings per share (EPS) were $6.22, surpassing the consensus estimate of $6.13. Looking ahead, HCA projects its 2025 EPS to range between $24.05 and $25.85, with anticipated revenues between $72.8 billion and $75.8 billion. This optimistic outlook is driven by an aging U.S. population and increased demand for medical procedures, particularly among elderly Medicare members. Analyst evaluations further underscore HCA's potential. A recent analysis rated the company at 91%, based on strong fundamentals and favorable valuation metrics. Conclusion Considering HCA's solid financial performance, positive earnings outlook, and favorable industry trends, the stock appears to have the potential to reach and possibly exceed the $390 mark. Investors should monitor market conditions and company-specific developments to make informed decisions.
NYSE:HCA
by swingstocktraders
HCA Advances as Tech StumblesHealthcare is the leading sector so far this year, and some traders may see opportunity in hospital operator HCA Healthcare. Today’s weekly chart considers the all-time high above $410 in October, followed by a substantial pullback. Prices stabilized early this year around $290 (near the low from last April) before bouncing. The stock also based around an earlier peak from June 2023. Both of those points suggest new support has been established at old resistance. Second, last week saw a bullish inside candle, which may suggest HCA has stabilized after the fourth quarter’s big slide. Third, holding current levels or moving upward through Friday would produce the highest weekly close since November. Finally, sector rotation may be an issue with investors mostly shunning large-cap growth in favor of non-cyclical safe havens. (Recent weeks also show outperformance in consumer staples and REITs, according to TradeStation Data.) TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NYSE:HCA
by TradeStation
1
Head & ShouldersThis pattern consists of 2 shoulders that should be in the same ballpark in price but are rarely the exact same price. The 2 shoulders should be close to the same distance from the head which is a high point between the 2 shoulders. T1 has just about been met. Sometimes t1 is all we get. Earnings 10-24 BMO. No recommendation HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
NYSE:HCA
by lauralea
HCA Entry, Volume, Target, StopEntry: with price above 294.02 Volume: with volume greater than 4.08M Target: 313.20 area Stop: Depending on your risk tolerance; Based on an entry of 294.03, 287.64 gets you 3/1 Reward to Risk Ratio. This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not take this trade based on my idea, do not follow anyone blindly, do your own analysis and due diligence. I am not a professional trader.
NYSE:HCALong
by tradepatiently
Watchlist 2023-04-25 $SPY $SPOT $FRC $KEY $HCA $SQMAMEX:SPY - was stuck in the +/- 1 range around the high volume node at 412 until it made a sharp dive in the after hours trading. The drop could likely be due to the aftermath of FRC reporting a drop in deposits after the crisis by 100 Billion, which spread fear of contagion to other regions. If SPY rejects the 412 area early on and breaks 410 support, expect lower prices to follow for at least a portion of the day. SPY has been stuck in a tight range for a few weeks but perhaps a catalyst like this is enough to allow bears to regain control. For further confirmation of a trend day, watch for: USI:ADD pinned near +\-2000 USI:VOLD ratio over +/- 3 USI:TICK cumulating past 0 wicking to +/-900 NYSE:SPOT - Qtrly Revenue Grew 14%, Led By Subscriber Gains. Up 2.3 ATRS on 3 RVOL trading over the 1.37 pivot top. Rvol is enough to sustain a large cap ATRs move as so so I [m not necessarily expecting a pulback to the 137 support but wil be prepared if we get it if the SPY remains weak. Else, want to give this a few minutes off the open, if 137 firms, looking for buy set ups and will then need to see a break of 141 PM high. NYSE:FRC - The troubled bank said lost half of its deposits at more than 100 Billion and Analysts reported deposit outflows were much worse than Wall Street estimates and at a "level that could prove very hard to come back from." FRC is in trouble under 12.60 pivot. Anyone who bought the second drop on march 20 AVVWAP is also very underwater. This could be a quick trade short off the open, but be cautions as this trade is so obvious that there is potential for a short squeeze. NYSE:KEY - also looking like a good region bank short below 10.86 which is range support AND the yearly pivot support. Key reported losses on April 20 and has been cascading since. Other watches: NYSE:SQM - huge move PD as chile plans to nationalize lithium reserves. Bad news for SQM. Watching for weakness under 666 or strength over 67.50. NYSE:HCA - day 3 continuation break over 289
NYSE:HCA
by UnclePennybagss
HCA - Is Healthcare Worth Considering Now? Given that we are coming out of pandemic now and the pressure on hospitals is going to reduce is it worth picking up hospital operator for a potential 30% upside? Fundamental indicators: Revenue and Profits - demonstrated consistent long-term earnings growth over the past 10 years. However, increasing wages are eating into the profits Profit margin - low margin with 8.7% in 2021 P/E - very attractive 9.9x ratio compared to 22x for the whole market Liabilities - historically liabilities are on the level with assets, and debt to shareholder equity is negative Technical Analysis (Elliott Waves): Since March 2020 crash HCA has enjoyed a good rally peaking in April 2022 The sharp drop from the historic high is indicating that there was an Expanded Flat correction formed with an impulse in wave C Since then there was a zigzag like movement to the upside which indicates that an Ending Diagonal is potentially forming. However, at this stage it is difficult to predict how the waves are going to develop at this stage If the proposed scenario is correct we can expect waves 3 and 5 also formed by zigzags and correction in wave 4 intruding into the territory of wave 1 Let's see how it develops further. What do you think about this scenario for HCA Healthcare Inc ? Please share your thoughts in the comments and like this idea if you agree wit it. Also let me know if you would like to see other stocks analysed using Elliott Waves. Thanks
NYSE:HCALong
by vitalalyt